Quantcast

Latest Brachytherapy Stories

2014-07-07 08:27:42

KENNEWICK, Wash., July 7, 2014 /PRNewswire/ -- Advanced Medical Isotope Corporation ("AMIC") (OTCBB: ADMD), a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications, today announced that Battelle, has acquired approximately 11% of AMIC's outstanding Common Stock. Battelle is a leading international science and technology enterprise that explores emerging areas of science and develops...

2014-07-03 23:07:42

AccuBoost exhibits at American Brachytherapy Society's 2014 Annual Meeting. Tyngsboro, Massachusetts (PRWEB) July 03, 2014 Advanced Radiation Therapy is pleased to recognize the substantial attention and excitement that the AccuBoost® technology received at the recent American Brachytherapy Society (ABS) meeting held in San Diego. In a number of oral and poster presentations, the very positive results of clinical experience with the technology, clinically referred to as...

2014-06-20 23:08:57

AccuBoost announces first breast cancer patient treatments at Northern Nevada Radiation Oncology. Tyngsboro, MA (PRWEB) June 20, 2014 Advanced Radiation Therapy, creators of the AccuBoost Breast Brachytherapy technology, is pleased to announce that Northern Nevada Radiation Oncology of Reno, Nevada has signed an agreement to offer the AccuBoost Treatment option to their patients undergoing breast conservation therapy(BCT). Treatments utilizing the AccuBoost technique under the direction...

2014-06-09 12:29:27

LONDON, June 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Japanese Urological Devices Markethttp://www.reportbuyer.com/pharma_healthcare/medical_supplies/hospital_supplies/japanese_urological_devices_market.html In 2012, the Japanese market for urological devices was valued at $411.9 million.This report analyzes the markets for the treatment of benign prostate hyperplasia (BPH), prostate cancer, urinary incontinence as well as urinary and kidney...

2014-06-05 08:28:20

KENNEWICK, Wash., June 5, 2014 /PRNewswire/ -- Advanced Medical Isotope Corporation ("AMIC") (OTCBB: ADMD), a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications, today announced that Dr. Darrell R. Fisher has been appointed to the AMIC Medical Advisory Board, joining Chairman Dr. Barry D. Pressman. http://photos.prnewswire.com/prnvar/20140115/CL46762LOGO Dr. Fisher is known...

2014-06-04 12:29:19

Skyline Radiation Oncology, first in state to use Clarity, now also offers precise stereotactic radiotherapy for prostate cancer due to increased disease targeting confidence TUSTIN, Calif., June 4, 2014 /PRNewswire/ -- Skyline Radiation Oncology's acquisition of Elekta's Clarity® soft tissue visualization system is enabling physicians to continuously track the motion of the prostate during the delivery of radiation therapy. With continuous intrafractional image guidance, Skyline is...

2014-05-20 23:09:02

Funds will expand commercialization of market-leading early-stage breast cancer treatment. (PRWEB) May 20, 2014 ALISO VIEJO, Calif: Cianna Medical, Inc., a women’s health company, today announced it has secured a $10 million financing deal with GE Capital’s Healthcare Financial Services business. The funds will be used to further product development efforts in the breast conservation therapy (BCT) market, as well as expand the commercialization of the company’s SAVI® breast...

2014-05-08 08:33:23

STOCKHOLM, May 8, 2014 /PRNewswire/ -- Elekta announced today that it has appointed Asa Hedin as Executive Vice President (EVP) Corporate Strategy, assuming responsibility for Strategy, Marketing and Education & Training. Elekta also announced that Maurits Wolleswinkel has been appointed as EVP Neuroscience from August 1, 2014. Asa Hedin will continue to report to Elekta's new CEO, Niklas Savander, as a member of the Executive Management team. She has led Elekta Neuroscience...

2014-05-01 23:07:27

Cianna Medical: Early-stage breast cancer treatment enables more women to opt for partial breast radiation. Aliso Viejo, CA (PRWEB) May 01, 2014 Cianna Medical, Inc., a women’s health company, today announced the results of a trial examining the long-term side effects of strut-based brachytherapy for early-stage breast cancer. According to researchers, treatment with SAVI® breast brachytherapy resulted in very low rates of late toxicities, even in patients with minimal space...

2014-04-24 10:55:15

The American Society for Radiation Oncology (ASTRO) has issued a new guideline, “The Role of Postoperative Radiation Therapy for Endometrial Cancer: An ASTRO Evidence-Based Guideline,” that details the use of adjuvant radiation therapy in the treatment of endometrial cancer. The guideline’s executive summary is published in the May-June 2014 issue of Practical Radiation Oncology (PRO), the official clinical practice journal of ASTRO. The full-length guideline is available as an...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related